Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
about
Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Safety and dose-dependency of ...... s, with or without inhibitors.
@en
Safety and dose-dependency of ...... s, with or without inhibitors.
@nl
type
label
Safety and dose-dependency of ...... s, with or without inhibitors.
@en
Safety and dose-dependency of ...... s, with or without inhibitors.
@nl
prefLabel
Safety and dose-dependency of ...... s, with or without inhibitors.
@en
Safety and dose-dependency of ...... s, with or without inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Safety and dose-dependency of ...... ts, with or without inhibitors
@en
P2093
J B Lawrence
J Burggraaf
J Frieling
M Moerland
P2860
P304
P356
10.1111/HAE.13357
P577
2017-10-05T00:00:00Z